When Food and Drug Administration Commissioner Scott Gottlieb, MD, announced a new agency-wide initiative last summer called the Digital Health Innovation Plan, the goal was to foster “innovation at the intersection of ...

With the unanimous endorsement from a Food and Drug Administration advisory committee that Spark Therapeutics’ Luxturna gene therapy for biallelic RPE65 mutation-associated retinal dystrophy should receive full FDA ...

The workshop on Ophthalmic Digital Health, a collaboration of the Food and Drug Administration and a host of medical societies that aims to explore safety and effectiveness issues of digital health in the ophthalmology ...

What’s Happening in the Month Ahead: October 2017 The Food and Drug Administration along with a host of professional societies, including the American Academy of Ophthalmology, American Society of Cataract and ...

The race to find an effective treatment for geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD) for which no approved treatment exists, has zeroed in on the complement pathway – and among ...

When Veracity Innovations LLC launched its new product at the 2017 American Society of Cataract and Refractive Surgery meeting in Los Angeles, the company was already in talks that led to its acquisition by Carl Zeiss ...

Stopping growth factors that create damage in the eye has proven lucrative. Lucentis (ranibizumab, Roche/Genentech) achieved sales of $1.8 billion in 2016 outside the US alone, and $1.46 billion within the US. Making ...

What’s Happening in the Month Ahead: September 2017 Ocugen, fresh off getting FDA orphan drug designation for OCU300-brimonidine to treat ocular graft rejection, will participate in the 19th annual Rodman-Renshaw ...

Strathspey Crown LLC has been granted the first patent on an intraocular lens (IOL) that includes a video camera, an LED display, and cellular, WiFi and Bluetooth capabilities, among other things. The possibility of ...